The relationship between vaccination and uveitis: A comprehensive review of immune response, risk assessment, and clinical implications

Abstract

Uveitis, an intraocular inflammatory condition, can lead to significant visual impairment and is often associated with abnormal immune system activation. While vaccination stands as a pivotal defense against numerous infectious diseases, its safety and effectiveness in individuals with uveitis have come under heightened scrutiny. This concern arises from the potential impact of both the disease itself and immunosuppressive treatments on immune function. Several studies have drawn connections between various vaccines and the onset of uveitis, particularly hepatitis B, human papillomavirus, and influenza vaccines. Furthermore, though exceedingly rare, instances of intraocular inflammatory following COVID-19 vaccination have been documented, adding another layer of complexity. This review delves into the intricate relationship between vaccination and uveitis, assesses the vaccination risks for those afflicted, and explores the underlying mechanisms behind vaccine-induced uveitis. Finally, it offers recommendations for vaccination in uveitis patients and emphasizes the imperative for further investigation to unravel the complex dynamics between vaccines and uveitis, ultimately informing clinical practice.

Keywords

COVID-19 / immunity / uveitis / vaccination / vaccine-associated uveitis

References

[1] Prete M , Dammacco R , Fatone MC , Racanelli V . Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. Clin Exp Med. 2016; 16 (2): 125- 136.

[2] Aboul NSH , Hassan LM , El Zanaty RT , et al. Behçet uveitis: current practice and future perspectives. Front Med. 2022; 9: 968345.

[3] Leal I , Steeples LR , Wong SW , et al. Update on the systemic management of noninfectious uveitis in children and adolescents. Surv Ophthalmol. 2024; 69 (1): 103- 121.

[4] Burkholder BM , Jabs DA . Uveitis for the non-ophthalmologist. BMJ. 2021; 372: m4979.

[5] Chang MH , Shantha JG , Fondriest JJ , Lo MS , Angeles-Han ST . Uveitis in children and adolescents. Rheum Dis Clin N Am. 2021; 47 (4): 619- 641.

[6] Pang T , Du L , Li F , et al. Association of apoptosis genes in PDCD1 but not PDCD1LG2, FAS, and FASLG with pediatric idiopathic uveitis in Han Chinese. Pediatr Res. 2020; 87 (4): 634- 638.

[7] Zhang J , Zhou P , Hu S , Qi J . Meta-analysis of the genetic association between PTPN22 and CTLA-4 variants and risk of uveitis. Ophthalmic Res. 2022; 65 (3): 264- 275.

[8] Wang Q , Su G , Tan X , et al. UVEOGENE: an SNP database for investigations on genetic factors associated with uveitis and their relationship with other systemic autoimmune diseases. Hum Mutat. 2019; 40 (3): 258- 266.

[9] Habot-Wilner Z , Neri P , Okada AA , et al. COVID vaccineassociated uveitis. Ocul Immunol Inflamm. 2023; 31 (6): 1198- 1205.

[10] Falagas ME , Zarkadoulia E . Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review. Curr Med Res Opin. 2008; 24 (6): 1719- 1741.

[11] Dubé E , Laberge C , Guay M , Bramadat P , Roy R , Bettinger J . Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013; 9 (8): 1763- 1773.

[12] Patel KG , Hilton T , Choi RY , Abbey AM . Uveitis and posterior ophthalmic manifestations following the SARS-CoV-2 (COVID-19) vaccine. Ocul Immunol Inflamm. 2022; 30 (5): 1142- 1148.

[13] Benage M , Fraunfelder FW . Vaccine-associated uveitis. Mo Med. 2016; 113 (1): 48- 52.

[14] Cunningham ET, Jr. , Moorthy RS , Fraunfelder FW , Zierhut M . Vaccine-associated uveitis. Ocul Immunol Inflamm. 2019; 27 (4): 517- 520.

[15] Cunningham ET, Jr . Moorthy RS: vaccine-associated posterior uveitis. Retina. 2020; 40 (4): 595- 598.

[16] Fraunfelder FW , Suhler EB , Fraunfelder FT . Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol. 2010; 29 (1): 26- 29.

[17] Holt HD , Hinkle DM , Falk NS , Fraunfelder FT , Fraunfelder FW . Human papilloma virus vaccine associated uveitis. Curr Drug Saf. 2014; 9 (1): 65- 68.

[18] Zhou W , Pool V , Iskander JK , et al. Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)--United States, 1991-2001. MMWR Surveill Summ. 2003; 52 (1): 1- 24.

[19] Pan L , Zhang Y , Cui Y , Wu X . Bilateral uveitis after inoculation with COVID-19 vaccine: a case report. Int J Infect Dis. 2021; 113: 116- 118.

[20] Testi I , Brandão-de-Resende C , De-La-Torre A , et al. Ocular inflammatory events following COVID-19 vaccination in the paediatric population: a multinational case series. Ocul Immunol Inflamm. 2024; 32 (7): 1237- 1242.

[21] Chaudry E , Singh G , Khan H , Bedi H , Hanna NG . Post-COVID-19 vaccine uveitis: a case series. J Fr Ophtalmol. 2023; 46 (7): 720- 725.

[22] Singh RB , Parmar UPS , Kahale F , Agarwal A , Tsui E . Vaccineassociated uveitis after COVID-19 vaccination: vaccine adverse event reporting system database analysis. Ophthalmology. 2023; 130 (2): 179- 186.

[23] Kim J , Kwon HY , Ahn SJ . COVID-19 vaccine-associated uveitis in patients with a history of uveitis. JAMA Ophthalmol. 2024; 142 (6): 522- 528.

[24] Waseem S , Ahmed SH , Fatima S , Shaikh TG , Ahmed J . SARS-CoV-2 vaccination and uveitis: are they linked? Ann Med Surg (Lond). 2022; 81: 104472.

[25] Ferrand N , Accorinti M , Agarwal M , et al. COVID-19 vaccination and uveitis: epidemiology, clinical features and visual prognosis. Ocul Immunol Inflamm. 2022; 30 (5): 1265- 1273.

[26] Sanjay S , Kawali A . Comment on: COVID-19 vaccine-associated reactivation of uveitis. Indian J Ophthalmol. 2022; 70 (1): 342- 343.

[27] Forrester JV . Uveitis: pathogenesis. Lancet. 1991; 338 (8781): 1498- 1501.

[28] Broekhuyse RM , Kuhlmann ED , Winkens HJ . Experimental autoimmune anterior uveitis (EAAU). III. Induction by immunization with purified uveal and skin melanins. Exp Eye Res. 1993; 56 (5): 575- 583.

[29] Donoso LA , Merryman CF , Shinohara T , Sery TW , Smith A . Santigen. Experimental autoimmune uveitis following immunization with a small synthetic peptide. Arch Ophthalmol. 1987; 105 (6): 838- 840.

[30] Kiser PD . Retinal pigment epithelium 65 kDa protein (RPE65): an update. Prog Retin Eye Res. 2022; 88: 101013.

[31] Nakamura H , Yamaki K , Kondo I , Sakuragi S . Experimental autoimmune uveitis induced by immunization with retinal pigment epithelium-specific 65-kDa protein peptides. Curr Eye Res. 2005; 30 (8): 673- 680.

[32] McMaster PR , Wong VA , Kyriakos M , Owens JD . Prevention of autoimmune uveitis by competitive immunization with bovine gamma globulin. Ann Ophthalmol. 1985; 17 (12): 779- 783.

[33] Soriano A , Soriano M , Oliva R , Smith WM . Editorial: uveitis: insights into pathogenesis and treatment. Front Med. 2022; 9: 1033817.

[34] Egwuagu CE , Alhakeem SA , Mbanefo EC . Uveitis: molecular pathogenesis and emerging therapies. Front Immunol. 2021; 12: 623725.

[35] Chen S , Huang W , Wan Q , et al. Investigation of the acute pathogenesis of spondyloarthritis/HLA-B27-associated anterior uveitis based on genome-wide association analysis and single-cell transcriptomics. J Transl Med. 2024; 22 (1): 271.

[36] Wu J , Fang C , Zhou Y , Wang M , Li Q , Dong S . Causal role of immune cells in uveitis: Mendelian randomization study. Front Immunol. 2024; 15: 1402074.

[37] Zhang M , Zhang X . T cells in ocular autoimmune uveitis: pathways and therapeutic approaches. Int Immunopharmacol. 2023; 114: 109565.

[38] Wu X , Tao M , Zhu L , Zhang T , Zhang M . Pathogenesis and current therapies for non-infectious uveitis. Clin Exp Med. 2023; 23 (4): 1089- 1106.

[39] Sugita S , Futatsugi Y , Ishida M , Edo A , Takahashi M . Retinal pigment epithelial cells derived from induced pluripotent stem (iPS) cells suppress or activate T cells via costimulatory signals. Int J Mol Sci. 2020; 21 (18): 6507.

[40] Quinn J , Salman A , Paluch C , et al. Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis. Sci Rep. 2024; 14 (1): 20033.

[41] Shirahama S , Okunuki Y , Lee MY , et al. Retinal microglia exacerbate uveitis by functioning as local antigen-presenting cells. bioRxiv. 2024.

[42] Sharma M , Pal P , Gupta SK . Microglial mediators in autoimmune Uveitis: bridging neuroprotection and neurotoxicity. Int Immunopharmacol. 2024; 136: 112309.

[43] Urban B , Bakunowicz-Łazarczyk A , Michalczuk M . Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Mediat Inflamm. 2014; 2014: 971417.

[44] Sng CC , Ang M , Barton K . Uveitis and glaucoma: new insights in the pathogenesis and treatment. Prog Brain Res. 2015; 221: 243- 269.

[45] Polack FP , Thomas SJ , Kitchin N , et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020; 383 (27): 2603- 2615.

[46] Beladiya J , Kumar A , Vasava Y , et al. Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials. Rev Med Virol. 2024; 34 (1): e2507.

[47] Sell S . How vaccines work: immune effector mechanisms and designer vaccines. Expert Rev Vaccines. 2019; 18 (10): 993- 1015.

[48] Zhao T , Huang X , Shu Y . Comparing the immune response and protective effect of COVID-19 vaccine under different vaccination strategies. Hum Vaccin Immunother. 2023; 19 (3): 2273155.

[49] Geckin B , Konstantin Föhse F , Domínguez-Andrés J , Netea MG . Trained immunity: implications for vaccination. Curr Opin Immunol. 2022; 77: 102190.

[50] Canouï E , Launay O . [History and principles of vaccination]. Rev Mal Respir. 2019; 36 (1): 74- 81.

[51] Connors J , Cusimano G , Mege N , et al. Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity. Hum Vaccin Immunother. 2023; 19 (3): 2267295.

[52] Sanjay S , Yathish GC , Singh Y , Kawali A , Mahendradas P , Shetty R . COVID-19 vaccination and recurrent anterior uveitis. Indian J Ophthalmol. 2022; 70 (12): 4445- 4448.

[53] Sanjay S , Kawali A , Mahendradas P . COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis. Indian J Ophthalmol. 2023; 71 (5): 2269- 2272.

[54] Chen KW , Chang EL , Sheridan AM , Papaliodis GN . Tubulointerstitial nephritis and uveitis syndrome (TINU) following COVID-19 vaccination. Am J Ophthalmol Case Rep. 2023; 31: 101869.

[55] Lin CY , Chien HJ . Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination. BMC Ophthalmol. 2023; 23 (1): 360.

[56] Marinho PM , Nascimento H , Romano A , Muccioli C , Belfort R, Jr . Diffuse uveitis and chorioretinal changes after yellow fever vaccination: a re-emerging epidemic. Int J Retina Vitreous. 2019; 5 (1): 30.

[57] Biancardi AL , Moraes HV, Jr . Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm. 2019; 27 (4): 521- 523.

[58] Volkov L , Grard G , Bollaert PE , et al. Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report. BMC Infect Dis. 2020; 20 (1): 116.

[59] Hwang JH . Uveitis after COVID-19 vaccination. Case Rep Ophthalmol. 2022; 13 (1): 124- 127.

[60] Cho SK , Wu XN , Amaratunge C . Acute uveitis following AstraZeneca COVID-19 vaccination. Ocul Immunol Inflamm. 2023; 31 (6): 1295- 1298.

[61] Fekri S , Khorshidifar M , Dehghani MS , Nouri H , Abtahi SH . Acute macular neuroretinopathy and COVID-19 vaccination: case report and literature review. J Fr Ophtalmol. 2023; 46 (1): 72- 82.

[62] ElSheikh RH , Haseeb A , Eleiwa TK , Elhusseiny AM . Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021; 29 (6): 1207- 1209.

[63] Richards PJ , Wingelaar MJ , Armbrust KR , Kopplin LJ . Uveitis reactivation following recombinant zoster vaccination. Am J Ophthalmol Case Rep. 2021; 23: 101115.

[64] Gonome T , Suzuki Y , Metoki T , Takahashi S , Nakazawa M . Acute posterior multifocal placoid pigment epitheliopathy and granulomatous uveitis following influenza vaccination. Am J Ophthalmol Case Rep. 2016; 4: 60- 63.

[65] Rothova A , de Groot JD , Mudrikova T . Reactivation of acute retinal necrosis after flu H1N1 vaccination. Br J Ophthalmol. 2011; 95 (2): 291.

[66] Sood AB , O’Keefe G , Bui D , Jain N . Vogt-koyanagi-harada disease associated with hepatitis B vaccination. Ocul Immunol Inflamm. 2019; 27 (4): 524- 527.

[67] Abou-Samra A , Tarabishy AB . Multiple evanescent white dot syndrome following intradermal influenza vaccination. Ocul Immunol Inflamm. 2019; 27 (4): 528- 530.

[68] Yang J.-s , Chen C.-l , Hu Y.-z , Zeng R . Multiple evanescent white dot syndrome following rabies vaccination: a case report. BMC Ophthalmol. 2018; 18 (1): 312.

[69] Gonome T , Suzuki Y , Metoki T , Takahashi S and Nakazawa M: Acute posterior multifocal placoid pigment epitheliopathy and granulomatous uveitis following influenza vaccination. American Journal of Ophthalmology Case Reports, 2016, 4: 60- 63.

[70] Xu Y , Shen W . Presumed recurrent MEWDS following covid-19 vaccination. Ocul Immunol Inflamm. 2021; 29 (6): 1234- 1237.

[71] Brunet de Courssou JB , Tisseyre M , Hadjadj J , et al. De novo vogtkoyanagi-harada disease following Covid-19 vaccine: a case report and literature overview. Ocul Immunol Inflamm. 2022; 30 (5): 1292- 1295.

[72] Ferrini W , Aubert V , Balmer A , Munier FL , Abouzeid H . Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl. Pediatrics. 2013; 132 (4): e1035- e1038.

[73] Cam F , Gok G , Celiker H . Granulomatous anterior uveitis following mRNA-based COVID-19 vaccination: a case report. Indian J Ophthalmol. 2023; 71 (3): 1033- 1035.

[74] Renisi G , Lombardi A , Stanzione M , Invernizzi A , Bandera A , Gori A . Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis. 2021; 110: 95- 97.

[75] Ye H , Feng H , Zhao P , Fei P . Case report: posterior uveitis after divalent human papillomavirus vaccination in an asian female. Optom Vis Sci. 2020; 97 (6): 390- 394.

[76] Bellur S , Zeleny A , Patronas M , Jiramongkolchai K , Kodati S . Bilateral acute macular neuroretinopathy after COVID-19 vaccination and infection. Ocul Immunol Inflamm. 2023; 31 (6): 1222- 1225.

[77] Mudie LI , Zick JD , Dacey MS , Palestine AG . Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. 2021; 29 (4): 741- 742.

[78] Tao Y , Chang LB , Zhao M , Li XX . Two cases of exudative retina detachment and uveitis following H1N1 influenza vaccination. Chin Med J (Engl). 2011; 124 (22): 3838- 3840.

[79] Oh J , Park S , Park J , et al. Global burden of vaccine-associated uveitis and their related vaccines, 1967-2023. Br J Ophthalmol. 2024-325985.

[80] Lafay C , Assad Z , Ouldali N , et al. Increased incidence of pediatric uveitis associated with the COVID-19 pandemic occurring before COVID-19 vaccine implementation: a time-series analysis. J Pediatr. 2023; 263: 113682.

[81] Habot-Wilner Z , Neri P , Okada AA , et al. COVID vaccineassociated uveitis. Ocul Immunol Inflamm. 2023; 31 (6): 1198- 1205.

[82] Cherif YYS , Djeffal C , Abu Serhan H , et al. The characteristics of COVID-19 vaccine-associated uveitis: a summative systematic review. Vaccines (Basel). 2022; 11 (1): 69.

[83] Mahendradas P , Mishra SB , Sangoram R , et al. Ocular manifestations following COVID-19 vaccination. J Ophthalmic Inflamm Infect. 2023; 13 (1): 44.

[84] Yasaka Y , Hasegawa E , Keino H , et al. A multicenter study of ocular inflammation after COVID-19 vaccination. Jpn J Ophthalmol. 2023; 67 (1): 14- 21.

[85] De Domingo B , López M , Lopez-Valladares M , Ortegon-Aguilar E , Sopeña-Perez-Argüelles B , Gonzalez F . Vogt-koyanagi-harada disease exacerbation associated with COVID-19 vaccine. Cells. 2022; 11 (6): 1012.

[86] Xu K , Gao B , Li J , Xiang Y , Cao L , Zhao M . Clinical features, diagnosis, and management of COVID-19 vaccine-associated VogtKoyanagi-Harada disease. Hum Vaccin Immunother. 2023; 19 (2): 2220630.

[87] Pang K , Pan L , Guo H , Wu X . Case report: associated ocular adverse reactions with inactivated COVID-19 vaccine in China. Front Med. 2021; 8: 823346.

[88] Duran M . Bilateral anterior uveitis after BNT162b2 mRNA vaccine: case report. J Fr Ophtalmol. 2022; 45 (7): e311- e313.

[89] Alhamazani MA , Alruwaili WS , Alshammri B , Alrashidi S , Almasaud J . A case of recurrent acute anterior uveitis after the administration of COVID-19 vaccine. Cureus. 2022; 14 (3): e22911.

[90] Ortiz-Egea JM , Sánchez CG , López-Jiménez A , Navarro OD . Herpetic anterior uveitis following Pfizer-BioNTech coronavirus disease 2019 vaccine: two case reports. J Med Case Rep. 2022; 16 (1): 127.

[91] Jain A , Kalamkar C . COVID-19 vaccine-associated reactivation of uveitis. Indian J Ophthalmol. 2021; 69 (10): 2899- 2900.

[92] Zhong Z , Wu Q , Lai Y , et al. Risk for uveitis relapse after COVID-19 vaccination. J Autoimmun. 2022; 133: 102925.

[93] Zhong Z , Wu Q , Lai Y , et al. Early vs deferred non-messenger RNA COVID-19 vaccination among Chinese patients with a history of inactive uveitis: a randomized clinical trial. JAMA Netw Open. 2023; 6 (2): e2255804.

[94] Al-Allaf AW , Razok A , Al-Allaf Y , Aker L . Post-COVID-19 vaccine medium-vessel vasculitis and acute anterior uveitis, causation vs temporal relation; case report and literature review. Ann Med Surg (Lond). 2022; 75: 103407.

[95] Alli HD , Ally N , Mayet I , Joseph L , Omar SV , Madhi SA . Tubercular uveitis in uveitis cases in a high TB and HIV setting: a prospective Cohort study. Transl Vis Sci Technol. 2022; 11 (1): 9.

[96] Alli HD , Ally N , Mayet I , Dangor Z , Madhi SA . Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis. Surv Ophthalmol. 2022; 67 (3): 770- 792.

[97] Fried M , Conen D , Conzelmann M , Steinemann E . Uveitis after hepatitis B vaccination. Lancet. 1987; 2 (8559): 631- 632.

[98] Erkek E , Ayaslioglu E , Erkek AB , Kurtipek GS , Bagci Y . Response to vaccination against hepatitis B in patients with Behcet's disease. J Gastroenterol Hepatol. 2005; 20 (10): 1508- 1511.

[99] Kong K , Ding X , Ni Y . Resolution of Harada disease-like uveitis after quadrivalent human papillomavirus vaccination: a case report. Hum Vaccin Immunother. 2022; 18 (1): 1- 4.

[100] Wang LU , Chen FT , Wang JK , et al. Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: a case series. Taiwan J Ophthalmol. 2022; 12 (4): 465- 471.

[101] Dansingani KK , Suzuki M , Naysan J , Samson CM , Spaide RF , Fisher YL . Panuveitis with exudative retinal detachments after vaccination against human papilloma virus. Ophthalmic Surg Lasers Imaging Retina. 2015; 46 (9): 967- 970.

[102] Esmaeli-Gutstein B , Winkelman JZ . Uveitis associated with varicella virus vaccine. Am J Ophthalmol. 1999; 127 (6): 733- 734.

[103] Furer V , Eviatar T , Zisman D , et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis. 2021; 80 (10): 1330- 1338.

[104] Zou Y , Kamoi K , Zong Y , Zhang J , Yang M , Ohno-Matsui K . Vaccines and the eye: current understanding of the molecular and immunological effects of vaccination on the eye. Int J Mol Sci. 2024; 25 (9): 4755.

[105] Grillo AP , Fraunfelder FW . Keratitis in association with herpes zoster and varicella vaccines. Drugs Today. 2017; 53 (7): 393- 397.

[106] Watad A , Quaresma M , Brown S , et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - an update. Lupus. 2017; 26 (7): 675- 681.

[107] Reik L, Jr . Disseminated vasculomyelinopathy: an immune complex disease. Ann Neurol. 1980; 7 (4): 291- 296.

[108] Islam SM , El-Sheikh HF , Tabbara KF . Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases. Acta Ophthalmol Scand. 2000; 78 (5): 590- 592.

[109] Heydari-Kamjani M , Vante I , Uppal P , Demory Beckler M , Kesselman MM . Uveitis sarcoidosis presumably initiated after administration of Shingrix vaccine. Cureus. 2019; 11 (6): e4920.

[110] Moorthy RS , Moorthy MS , Cunningham ET, Jr . Drug-induced uveitis. Curr Opin Ophthalmol. 2018; 29 (6): 588- 603.

[111] Iijima H , Iida T , Murayama K , Imai M , Gohdo T . Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol. 1999; 127 (4): 477- 478.

[112] Cusick MF , Libbey JE , Fujinami RS . Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012; 42 (1): 102- 111.

[113] Younus R , Saeed MA , Arshad M , Farman S , Ahmad NM . Noninfectious uveitis in rheumatology: patterns, treatment, and outcomes. Cureus. 2023; 15 (6): e39965.

[114] Ott M , Nagamany T , Zandi S , et al. Herpetic anterior uveitis following COVID-19 vaccines: a case series. Front Med. 2023; 10: 1242225.

[115] Ichhpujani P , Parmar UPS , Duggal S , Kumar S . COVID-19 vaccineassociated ocular adverse effects: an overview. Vaccines (Basel). 2022; 10 (11): 1879.

[116] Wang MTM , Niederer RL , McGhee CNJ , Danesh-Meyer HV . COVID-19 vaccination and the eye. Am J Ophthalmol. 2022; 240: 79- 98.

[117] Neri P , Pichi F . COVID, the end of pandemic and vaccine-induced Uveitis: is this the showdown? Int Ophthalmol. 2023; 43 (12): 4395- 4397.

RIGHTS & PERMISSIONS

The Author(s). Eye & ENT Research published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.